id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2005-D-0226-0003,FDA,FDA-2005-D-0226,Guidance,Supporting & Related Material,GDL-Guidance,2005-11-22T05:00:00Z,2005,11,,,2008-04-11T23:47:02Z,,0,0,0900006480441ff2
FDA-2005-D-0226-0004,FDA,FDA-2005-D-0226,FDA,Notice,NAD-Notice of Availability of Data,2005-11-22T05:00:00Z,2005,11,2005-11-21T05:00:00Z,,2008-04-11T23:47:01Z,,0,0,0900006480441ff3
FDA-2005-D-0226-0001,FDA,FDA-2005-D-0226,FDA,Notice,NAD-Notice of Availability of Data,2005-09-13T04:00:00Z,2005,9,2005-09-12T04:00:00Z,2006-09-13T03:59:59Z,2008-04-11T23:47:01Z,,0,0,0900006480441fc4
FDA-2005-D-0226-0002,FDA,FDA-2005-D-0226,Guidance,Supporting & Related Material,GDL-Guidance,2005-09-13T04:00:00Z,2005,9,,,2008-04-11T23:47:02Z,,0,0,0900006480441ff1